|Bid||18.54 x 900|
|Ask||18.67 x 1300|
|Day's range||18.59 - 19.25|
|52-week range||10.15 - 26.16|
|Beta (5Y monthly)||0.98|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2021 - 13 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||24.57|
Radius (RDUS) reports a narrower loss but misses on sales in the first quarter as lead drug sales decline.
RDUS earnings call for the period ending March 31, 2021.
Radius Health (RDUS) delivered earnings and revenue surprises of 19.05% and -5.10%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?